A5F5N9 4-hydroxy-tetrahydrodipicolinate reductase MolNFT, Molecular NFT on GenesisL1

4-hydroxy-tetrahydrodipicolinate reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeiacakn67xgu5f4t5soqds3nww2cybfm36aeevtced3uo56glx3voa/metadata.json

IPFS of structure file:

bafybeieq3mg3v54mfyyvthlkk5acbxzloz2wb4w2tmxapvocfqreri5ezu/AF-A5F5N9-F1-model_v2.pdb

First NFT owner address (eip-55):

0x301437AEb4a9d7100Ad0D7b67830522a5E0Ab5e9

First NFT owner address (bech32):

genesis1xq2r0t4548t3qzks67m8svzj9f0q4d0fx803qm

Current NFT ID #88748 owner (web3):

0xC2c7ebda9f522D7F3af469396EfE2c25e34192Fa

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
88748
Accession (UniProt):
A5F5N9
Name::
4-hydroxy-tetrahydrodipicolinate reductase
Experimental Method:
Predicted structure
Sequence source:
VIBRIO CHOLERAE SEROTYPE O1 (STRAIN ATCC 39541 / CLASSICAL OGAWA 395 / O395)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A5F5N9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A5F5N9|DAPB_VIBC3 4-hydroxy-tetrahydrodipicolinate reductase OS=Vibrio cholerae serotype O1 (strain ATCC 39541 / Classical Ogawa 395 / O395) OX=345073 GN=dapB PE=3 SV=1 MVRIAIAGAAGRMGRNLVKATHQNPLSELGAGSERPESSLVGVDIGELCGIGKQGIVLVDNLEQAVEQFDVIIDFTAPASTLANLALCEQHGKKLVIGTTGFTDAQRQTIEQAAKKIPIVMAPNYSVGVNLVFKLLEKAAKVMGDYCDIEIIEAHHRHKVDAPSGTAIGMGEAIAHAMGNQLSDVAVYAREGITGERSRNEIGFATIRAGDIIGEHTAMFADIGERVEITHKATDRMTFANGAVKAAIWLAEQPAGFYTMTDVLGLNDL

A5F5N9 AF NFT

MOLNFT AF v1

NFT data

MOLNFT A5F5N9 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience